{"id":"https://openalex.org/W3205329948","doi":null,"title":"Impact of Heparin neutralization on Thrombin Generation Assay","display_name":"Impact of Heparin neutralization on Thrombin Generation Assay","publication_year":2021,"publication_date":"2021-10-14","ids":{"openalex":"https://openalex.org/W3205329948","mag":"3205329948"},"language":"en","primary_location":{"id":"pmh:oai:pure.unamur.be:openaire_cris_publications/46ef3c8f-b022-4724-bda5-0a3c3c01b6bc","doi":null,"is_oa":false,"landing_page_url":"https://researchportal.unamur.be/en/publications/46ef3c8f-b022-4724-bda5-0a3c3c01b6bc","pdf_url":null,"source":{"id":"https://openalex.org/S4406922457","display_name":"Repository of the University of Namur","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Didembourg, M, Douxfils, J, Carlo, A & Morimont, L 2021, 'Impact of Heparin neutralization on Thrombin Generation Assay'.","raw_type":"info:eu-repo/semantics/conferenceObject"},"volume":null,"type":"conference-paper","is_traditional":true,"indexed_in":[],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5017538074","display_name":"Marie Didembourg","orcid":"https://orcid.org/0000-0002-9170-0314","observed_orcids":["https://orcid.org/0000-0002-9170-0314"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Didembourg, Marie; id_orcid 0000-0002-9170-0314","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5078686392","display_name":"Jonathan Douxfils","orcid":"https://orcid.org/0000-0002-7644-5298","observed_orcids":["https://orcid.org/0000-0002-7644-5298"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Douxfils, Jonathan; id_orcid 0000-0002-7644-5298","raw_affiliation_strings":["Namur Thrombosis and Hemostasis Center"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Namur Thrombosis and Hemostasis Center","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5026126850","display_name":"Audrey Carlo","orcid":"https://orcid.org/0000-0002-2954-965X","observed_orcids":["https://orcid.org/0000-0002-2954-965X"]},"institutions":[{"id":"https://openalex.org/I4210087076","display_name":"Stago (France)","ror":"https://ror.org/0014agb17","country_code":"FR","type":"company","lineage":["https://openalex.org/I4210087076"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"Carlo, Audrey","raw_affiliation_strings":["Diagnostica Stago"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Diagnostica Stago","institution_ids":["https://openalex.org/I4210087076"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5034895260","display_name":"Laure Morimont","orcid":"https://orcid.org/0000-0001-9195-304X","observed_orcids":["https://orcid.org/0000-0001-9195-304X"]},"institutions":[{"id":"https://openalex.org/I4391767857","display_name":"Namur Research Institute for Life Sciences","ror":"https://ror.org/038bmak92","country_code":"BE","type":"facility","lineage":["https://openalex.org/I149768937","https://openalex.org/I4391767857"]}],"countries":["BE"],"is_corresponding":false,"raw_author_name":"Morimont, Laure","raw_affiliation_strings":["Namur Research Institute for Life Sciences"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Namur Research Institute for Life Sciences","institution_ids":["https://openalex.org/I4391767857"]}]}],"institutions":[],"countries_distinct_count":2,"institutions_distinct_count":2,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":0.0,"has_fulltext":true,"cited_by_count":0,"citation_normalized_percentile":{"value":0.0,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":null,"issue":null,"first_page":null,"last_page":null},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10881","display_name":"Blood Coagulation and Thrombosis Mechanisms","score":0.9740999937057495,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10881","display_name":"Blood Coagulation and Thrombosis Mechanisms","score":0.9740999937057495,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10285","display_name":"Venous Thromboembolism Diagnosis and Management","score":0.011300000362098217,"subfield":{"id":"https://openalex.org/subfields/2724","display_name":"Internal Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11721","display_name":"Blood properties and coagulation","score":0.006200000178068876,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/heparin-neutralization","display_name":"heparin neutralization","score":0.9819999933242798},{"id":"https://openalex.org/keywords/thrombin-generation-assay","display_name":"thrombin generation assay","score":0.8889999985694885},{"id":"https://openalex.org/keywords/enoxaparin","display_name":"enoxaparin","score":0.9210000038146973},{"id":"https://openalex.org/keywords/polybrene","display_name":"polybrene","score":0.8519999980926514},{"id":"https://openalex.org/keywords/hexadimethrine-bromide","display_name":"hexadimethrine bromide","score":0.8230000138282776},{"id":"https://openalex.org/keywords/low-molecular-weight-heparin","display_name":"low molecular weight heparin","score":0.9190000295639038},{"id":"https://openalex.org/keywords/anticoagulant-interference","display_name":"anticoagulant interference","score":0.8769999742507935},{"id":"https://openalex.org/keywords/coagulation-testing","display_name":"coagulation tests","score":0.7059999704360962},{"id":"https://openalex.org/keywords/endogenous-thrombin-potential","display_name":"endogenous thrombin potential","score":0.9100000262260437},{"id":"https://openalex.org/keywords/time-delay","display_name":"time delay","score":0.6710000038146973},{"id":"https://openalex.org/keywords/peak-height","display_name":"peak height","score":0.6230000257492065},{"id":"https://openalex.org/keywords/anticoagulant-reversal-agents","display_name":"anticoagulant reversal agents","score":0.574999988079071}],"concepts":[{"id":"https://openalex.org/C14086860","wikidata":"https://www.wikidata.org/wiki/Q337120","display_name":"Neutralization","level":3,"score":0.8594647645950317},{"id":"https://openalex.org/C2777557582","wikidata":"https://www.wikidata.org/wiki/Q190016","display_name":"Heparin","level":2,"score":0.5376912355422974},{"id":"https://openalex.org/C3018972837","wikidata":"https://www.wikidata.org/wiki/Q409166","display_name":"Thrombin generation","level":4,"score":0.48216408491134644},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.44976478815078735},{"id":"https://openalex.org/C144133560","wikidata":"https://www.wikidata.org/wiki/Q4830453","display_name":"Business","level":0,"score":0.3710818886756897},{"id":"https://openalex.org/C2777292125","wikidata":"https://www.wikidata.org/wiki/Q409166","display_name":"Thrombin","level":3,"score":0.3367961347103119},{"id":"https://openalex.org/C41008148","wikidata":"https://www.wikidata.org/wiki/Q21198","display_name":"Computer science","level":0,"score":0.3316330015659332},{"id":"https://openalex.org/C159047783","wikidata":"https://www.wikidata.org/wiki/Q7215","display_name":"Virology","level":1,"score":0.2712383270263672},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.1766713559627533},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.17584815621376038},{"id":"https://openalex.org/C2522874641","wikidata":"https://www.wikidata.org/wiki/Q808","display_name":"Virus","level":2,"score":0.1316470503807068},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.11780056357383728},{"id":"https://openalex.org/C89560881","wikidata":"https://www.wikidata.org/wiki/Q101026","display_name":"Platelet","level":2,"score":0.10122451186180115}],"mesh":[],"locations_count":1,"locations":[{"id":"pmh:oai:pure.unamur.be:openaire_cris_publications/46ef3c8f-b022-4724-bda5-0a3c3c01b6bc","doi":null,"is_oa":false,"landing_page_url":"https://researchportal.unamur.be/en/publications/46ef3c8f-b022-4724-bda5-0a3c3c01b6bc","pdf_url":null,"source":{"id":"https://openalex.org/S4406922457","display_name":"Repository of the University of Namur","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Didembourg, M, Douxfils, J, Carlo, A & Morimont, L 2021, 'Impact of Heparin neutralization on Thrombin Generation Assay'.","raw_type":"info:eu-repo/semantics/conferenceObject"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":0.9391000270843506,"display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W3202780367","https://openalex.org/W3205277166","https://openalex.org/W1997878082","https://openalex.org/W2087639596","https://openalex.org/W2087039130","https://openalex.org/W2055838174","https://openalex.org/W2005429417","https://openalex.org/W3174426073","https://openalex.org/W2323546089","https://openalex.org/W2090369222"],"abstract_inverted_index":{"Background:":[0],"Heparins":[1],"are":[2,19],"sulphated":[3],"glycosaminoglycans":[4],"mainly":[5],"used":[6],"as":[7,17,66,71,156,220,240,376],"an":[8,40],"anticoagulant":[9,51,97],"therapy":[10],"to":[11,21,38,86,94,107,172,280,314,350,392,434,439,462],"prevent":[12],"venous":[13],"thromboembolism.":[14],"However,":[15,375],"anticoagulants":[16],"heparinoids":[18,54],"known":[20,70],"impact":[22,110,194,412,447],"coagulation":[23],"tests":[24],"by":[25,61,203,250,304,308,335,344],"increasing":[26],"clotting":[27],"times":[28],"or":[29,73,213,236],"reducing":[30],"thrombin":[31,102],"generation":[32,103],"in":[33,121,170,185,189,227,259,384,400],"the":[34,44,50,88,96,147,165,221,229,241,251,256,263,273,283,324,338,341,351,360,363,372,379,394,420,423],"test":[35],"sample.":[36],"Therefore,":[37],"ensure":[39],"unbiased":[41],"evaluation":[42],"of":[43,49,53,90,99,127,177,195,223,253,285,362,371,386,397,402,442],"patient":[45],"coagulability":[46],"status,":[47],"neutralization":[48],"effect":[52,98,284],"is":[55],"necessary.":[56],"This":[57,83,405],"can":[58],"be":[59],"achieved":[60],"using":[62,151],"neutralizing":[63,197,216,429,454,464],"agents":[64,198],"such":[65],"hexadimethrine":[67],"bromide,":[68],"also":[69],"polybrene,":[72],"Hepa-remove\u00ae":[74,93,161,237,265,421,451],"(5-Diagnostics,":[75],"Switzerland),":[76],"a":[77,122,440],"newly":[78],"developed":[79],"synthetic":[80],"tripeptide.":[81],"Aims:":[82],"study":[84,406],"aimed":[85],"assess":[87],"capacity":[89,217,465],"polybrene":[91,254,305,409,431],"and":[92,106,140,160,179,187,210,272,298,311,367,381,425],"neutralize":[95,282,436],"enoxaparin":[100,326,437],"on":[101,111,146,199,317,413,448,466],"assay":[104,417],"(TGA)":[105],"evaluate":[108],"their":[109,428],"this":[112,260],"test.":[113],"Method:":[114],"Low":[115],"molecular":[116],"weight":[117],"heparin":[118,232,373],"was":[119,144,201,218,238,248,347,432],"spiked":[120,319],"normal":[123],"pooled":[124],"plasma":[125,175,205,230],"composed":[126],"50":[128],"healthy":[129],"individuals":[130],"at":[131,255,323],"different":[132],"concentrations,":[133],"0":[134],"[=sterile":[135],"saline":[136],"solution],":[137],"0.2,":[138],"0.4":[139],"0.6":[141,330,443],"UI/mL.":[142],"TGA":[143,246],"assessed":[145,188,202],"ST":[148],"Genesia":[149],"system":[150],"STGThromboScreen":[152],"-TM":[153],"(Stago,":[154],"France)":[155],"triggering":[157,166],"reagent.":[158],"Polybrene":[159,212,235,278],"were":[162,183,306],"added":[163],"into":[164],"reagent":[167],"upon":[168],"reconstitution":[169],"order":[171],"obtain":[173],"final":[174],"concentrations":[176],"0.025mg/mL":[178],"0.166mg/mL,":[180],"respectively.":[181],"Analyses":[182],"performed":[184],"duplicate":[186],"three":[190],"independent":[191],"runs.":[192],"The":[193,215,287,332,356,450],"these":[196,398],"TG":[200,316,414,459],"comparing":[204],"(without":[206],"heparin)":[207],"treated":[208,233],"with":[209,234,320,445],"without":[211,231],"Hepa-remove\u00ae.":[214],"measured":[219],"percentages":[222],"change":[224],"from":[225],"baseline":[226,242,315,352,364,395],"which":[228,346],"considered":[239],"condition.":[243],"Results:":[244],"No":[245],"parameter":[247],"impacted":[249,378,422,457],"presence":[252],"concentration":[257,327,441],"tested":[258,328],"study.":[261],"On":[262,337],"opposite,":[264],"significantly":[266],"reduces":[267],"he":[268],"Lag":[269],"Time":[270],"(LT)":[271],"Time-to-peak":[274],"(Ttp)":[275],"(p-value<":[276],"0.05).":[277],"permits":[279],"fully":[281,435],"enoxaparin.":[286,403,467],"residual":[288],"Endogenous":[289],"Thrombin":[290],"Potential":[291],"(ETP),":[292],"mean":[293],"Velocity":[294],"Rate":[295],"Index":[296],"(mVRI)":[297],"Peak":[299],"Height":[300],"(PH)":[301],"after":[302],"treatment":[303],"increased":[307],"5.1%,":[309],"8.6%":[310],"6.6%":[312],"compared":[313,349],"NPP":[318],"saline,":[321],"even":[322,383],"highest":[325],"(i.e.,":[329],"IU/mL).":[331],"LT":[333,380,424],"decreased":[334,343],"6.4%.":[336],"other":[339],"hand,":[340],"Ttp":[342,382],"3.9%":[345],"significant":[348],"(p-value":[353],"=":[354],"0.048).":[355],"Heparemove":[357],"\u00ae":[358],"permitted":[359],"recovery":[361],"ETP,":[365],"mVRI":[366],"PH":[368],"values":[369],"regardless":[370],"concentration.":[374],"it":[377,388],"absence":[385,401],"heparin,":[387],"does":[389],"not":[390],"permit":[391],"recover":[393],"value":[396],"parameters":[399,460],"Conclusion:":[404],"showed":[407,452],"that":[408],"had":[410],"no":[411,446],"under":[415],"our":[416],"conditions;":[418],"while":[419],"Ttp.":[426],"Regarding":[427],"capacity,":[430,455],"able":[433],"up":[438],"UI/mL":[444],"TG.":[449],"acceptable":[453],"but":[456],"some":[458],"independently":[461],"its":[463]},"counts_by_year":[],"updated_date":"2026-11-08T12:12:28.789561","created_date":"2021-10-25T00:00:00"}